Cargando…
Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
Gene expression imbalances were measured for tyrosine kinase (TK) genes using Nanostring in 19 samples of inflammatory myofibroblastic tumor (IMT). All cases were immunohistochemically stained with anaplastic lymphoma kinase (ALK) and pan-tropomyosin-related-kinase (pan-Trk) antibodies. Five cases w...
Autores principales: | Kurihara, Taisei, Suehara, Yoshiyuki, Akaike, Keisuke, Hayashi, Takuo, Kohsaka, Shinji, Ueno, Toshihide, Hasegawa, Nobuhiko, Takagi, Tatsuya, Sasa, Keita, Okubo, Taketo, Kim, Youngji, Mano, Hiroyuki, Yao, Takashi, Kaneko, Kazuo, Saito, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603320/ https://www.ncbi.nlm.nih.gov/pubmed/33127954 http://dx.doi.org/10.1038/s41598-020-75596-3 |
Ejemplares similares
-
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing’s sarcoma
por: Tanabe, Yu, et al.
Publicado: (2018) -
Detection of circulating sarcoma tumor cells using a microfluidic chip-type cell sorter
por: Hasegawa, Nobuhiko, et al.
Publicado: (2019) -
Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022) -
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022) -
RETRACTED ARTICLE: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2021)